Liquid Light closes $15 mln Series B funding round

Liquid Light, which develops and licenses process technology to make major chemicals from carbon dioxide, has raised a $15 million Series B funding round. New investors in the funding include Sustainable Conversion Ventures. Existing investors include VantagePoint Capital Partners, BP Ventures, Chrysalix Energy Venture Capital and Osage University Partners.

Otonomy scores $49 mln Series D funds

Otonomy said Wednesday that it has closed $49 million in Series D funding. The investors included Perceptive Advisors, Federated Kaufmann Funds, OrbiMed Advisors, Novo Ventures, TPG Biotech, Avalon Ventures, Domain Associates, RiverVest Venture Partners, Aperture Venture Partners and Osage University Partners. Based in San Diego, Calif., Otonomy is a biopharmaceutical company that develops treatments for ear disorders and diseases.

VC-backed Liquid Light adds Bayer veteran to executive team

Liquid Light has hired Dave Law as executive vice president of operations. Previously, Law worked at Bayer. Liquid Light is a provider of process technology that makes major chemicals from carbon dioxide. Its backers include VantagePoint Capital Partners, BP Ventures, Chrysalix Energy Venture Capital and Osage University Partners.

Kolltan Pharmaceuticals rakes in $60 mln

Kolltan Pharmaceuticals said Wednesday that it has secured $60 million in Series D financing. The investors included KLP Enterprises, Deerfield Management, HBM Healthcare Investments Ltd., Purdue Pharma and Osage University Partners. Based in New Haven, Conn., Kolltan Pharmaceuticals is a biopharmaceutical company that targets receptor tyrosine kinases.

Kymeta Closes $50m Series C

Kymeta Corporation has closed a $50 million Series C financing to accelerate the company’s growth plans. Kymeta designs and manufactures satellite communication antennas and systems. Existing Kymeta investors including Bill Gates, Lux Capital and Liberty Global were joined in the financing by Osage University Partners and The Kresge Foundation.

eFFECTOR Therapeutics Raises $45 Million Series A

Biopharmaceutical company eFFECTOR Therapeutics has completed a $45 million Series A financing. Investors include U.S. Venture Partners, Abingworth, Novartis Venture Funds, SR One, Astellas Venture Management, Osage University Partners and Mission Bay Capital.

Cardioxyl Raises Series B Led By OrbiMed

Cardioxyl Pharmaceuticals has secured $28 million in a Series B financing led by OrbiMed Advisors. New investor Osage University Partners joined OrbiMed and returning investors New Enterprise Associates and The Aurora Funds in the financing.

Sera Prognostics Inks $19.3M Series A

Sera Prognostics Inc., a company developing tests to diagnose preterm birth and other pregnancy complications, has raised $19.3 million from a slew of investors including InterWest Partners, Domain Associates, Catalyst Health Ventures, UpStart Life Sciences Capital and Osage University Partners. The Series A financing will help fund clinical trials and the commercial launch of its preterm birth diagnostic test.

MC10 Closes on $12M Series B

Cambridge, Mass.-based MC10 has closed on $12 million in Series B financing led by new investor Braemar Energy Ventures. Existing shareholders North Bridge Venture Partners, Osage University Partners and Terawatt Ventures also contributed to the round. MC10 develops technology designed to transform high-performance electronics into systems that can bend, stretch and wrap into different shapes. The technology is applicable to sports, military and biomedical fields.

Aerie Pharmaceuticals Closes $30M Series B

Aerie Pharmaceuticals Inc., a biotechnology company focused on medical innovations in ophthalmology, has closed $30 million in Series B financing. Clarus Ventures and Sofinnova Ventures co-led the round, with participation from Osage University Partners and existing investors Alta Partners and TPG Biotech. Aerie Pharmaceuticals has offices in Research Triangle Park, N.C. and in Bridgewater, N.J.

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget